News | May 15, 2015

Accreditation for Cardiovascular Excellence Publishes New Standards for Electrophysiology and ICDs

Evidence-based guidelines offer comprehensive review of interventional procedures for heart rhythm disorders

Accreditation for Cardiovascular Excellence, standards, EP, ICDs, guidelines

May 15, 2015 — Accreditation for Cardiovascular Excellence (ACE) has just released the first-ever electrophysiology (EP) and implantable cardioverter defibrillator (ICD) standards for accreditation. Driven by the latest available clinical evidence, the EP and ICD standards are a comprehensive review of interventional procedures in patients and adults with heart rhythm disorders.

"The ACE Standards for Electrophysiology (EP) and Implantable Cardioverter Defibrillators (ICD) Accreditation will allow EP laboratories to evaluate themselves against other facilities performing similar procedures and have input from an unbiased body of experts to help promote quality improvement within their center," said Michael S. Katcher, M.D., FHRS, director of cardiac electrophysiology and pacing, North Shore Medical Center. "These standards meet the needs of the EP laboratory, because they include diagnostic and therapeutic procedures and the core functions of EP labs."

Prior to the development of the ACE standards, however, no broad based performance guidance had been published for quality care in the EP and ICD settings. The new ACE Standards define the current evidence-based best practices for a variety of diagnostic and interventional procedures and device implantation.

The ACE EP and ICD Standards will be launched at the ACE exhibit at the 2015 Heart Rhythm Society 2015 (HRS 2015) meeting, May 13-16, in Boston. 

For more information:

Related Content

Boston Scientific Launches Resonate Devices With HeartLogic Heart Failure Diagnostic
Technology | Implantable Cardioverter Defibrillator (ICD) | September 27, 2017
September 27, 2017 — Boston Scientific recently launched the Resonate family of...
Abbott Secures FDA Approval for MRI Compatibility on Ellipse ICD
Technology | Implantable Cardioverter Defibrillator (ICD) | September 22, 2017
Abbott announced U.S. Food and Drug Administration (FDA) approval for magnetic resonance (MR)-conditional labeling for...
Predictive Models May Help Determine Which Patients Benefit From ICDs
News | Implantable Cardioverter Defibrillator (ICD) | July 06, 2017
Two predictive models may help cardiologists decide which patients would most benefit from an implantable cardioverter...
Videos | Implantable Cardioverter Defibrillator (ICD) | June 01, 2017
Lucas Boersma, M.D., Ph.D., FESC, St.
The Unify ICD is one of the SJM devices in an FDA warning letter
Feature | Implantable Cardioverter Defibrillator (ICD) | April 14, 2017 | Dave Fornell
April 14, 2017 — The U.S. Food and Drug Administration (FDA) sent a warning letter to Abbott/St.
ICDs, non-ischemic cardiomyopathy, University of Alabama at Birmingham study, Circulation
News | Implantable Cardioverter Defibrillator (ICD) | January 18, 2017
A new study published in Circulation has found there is a 23 percent risk in reduction of all-cause mortality in non-...
ICDs, implantable cardioverter defibrillators, survival rate, elderly patients, JACC study
News | Implantable Cardioverter Defibrillator (ICD) | January 17, 2017
Of patients over age 65 who received an implantable cardioverter-defibrillator (ICD) after surviving sudden cardiac...
Overlay Init